BIEI (Premier Biomedical) FCF Margin %: -7,100.00% (As of Dec. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Premier Biomedical FCF Margin %?

Premier Biomedical BIEI FCF Margin % is -7,100.00% as of Dec. 2019.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Premier Biomedical's Free Cash Flow for the three months ended in Dec. 2019 was $-0.07 Mil. Premier Biomedical's Revenue for the three months ended in Dec. 2019 was $0.00 Mil. Therefore, Premier Biomedical's FCF Margin % for the quarter that ended in Dec. 2019 was -7,100.00%.

As of today, Premier Biomedical's current FCF Yield % is 0.00%.

The historical rank and industry rank for Premier Biomedical's FCF Margin % or its related term are showing as below:

BIEI' s FCF Margin % Range Over the Past 10 Years
Min: -2492.86   Med: 0   Max: 0
Current: -2492.86

BIEI's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.57 vs BIEI: -2492.86

Premier Biomedical FCF Margin % Related Terms

Premier Biomedical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Premier Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premier Biomedical FCF Margin % Chart

Premier Biomedical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
FCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -1,275.00 -1,117.50 -2,492.86

Premier Biomedical Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,400.00 -1,183.33 -2,725.00 -3,266.67 -7,100.00

BIEI vs PTXTQ, STNN, SBFM: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Premier Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Premier Biomedical FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Premier Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Premier Biomedical's FCF Margin % falls into.


Premier Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Premier Biomedical's FCF Margin for the fiscal year that ended in Dec. 2019 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2019 )/Revenue (A: Dec. 2019 )
=-0.349/0.014
=-2,492.86 %

Premier Biomedical's FCF Margin for the quarter that ended in Dec. 2019 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2019 )/Revenue (Q: Dec. 2019 )
=-0.071/0.001
=-7,100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -7,100.00% mean?
Premier Biomedical (BIEI) has a FCF Margin % of -7,100.00% as of Dec. 2019. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Premier Biomedical and its competitors.
Is Premier Biomedical's FCF Margin % too high?
Premier Biomedical's current FCF Margin % is -7,100.00%.
How does Premier Biomedical's FCF Margin % compare to PTXTQ and STNN?
Premier Biomedical's FCF Margin % of -7,100.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.57, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Premier Biomedical and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Premier Biomedical's current FCF Margin % is -7,100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premier Biomedical stock overvalued right now?
Premier Biomedical (BIEI) has a current FCF Margin % of -7,100.00%. The current FCF Margin % is -7,100.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Premier Biomedical (BIEI), the current FCF Margin % is -7,100.00% as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premier Biomedical Business Description

Address 1150 S. 8th Street, El Centro, CA, USA, 92243
Premier Biomedical Inc is engaged in a hemp based initiative, developing graphene enhanced formulations for a myriad of commercial and military applications and complementing new EV battery technology.